1-year base with two (2) option years, time and materials (TM) type task order to for the food and drug administration (FDA) and the office of center for drug evaluation and research (cder).
Ended Awarded Last action
- Contract number
- 75F40125F19018
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $242,925
Award facts
- Opportunity
-
- 75F40125R00124 Solicitation number
- Contract value 100% obligated
- $242,924.59 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Time and Materials
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$333,071 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Original award | $575,995 |
About this award
The Food and Drug Administration issued a $242,924.59 delivery order to Kaiva Strategies, LLC on September 26, 2025, under the Professional, Administrative, and Consulting Services (PACS) IDIQ for professional, administrative, and consulting services to the Office of Center for Drug Evaluation and Research.
This is a competitive 8(a) set-aside. Kaiva Strategies is a tribally-owned, minority-owned 8(a) joint venture small business. The PACS IDIQ is a $100 million Competitive 8(a) single-award vehicle running through August 2028.
Place of performance is Silver Spring, MD. The order runs for one year with two option years on a time and materials basis, with ultimate completion dated August 30, 2026. In FY2025, the order invoiced $513 thousand across 0.2 FTEs and 380 contractor hours at a blended rate of $1,351.16 per hour, with one subcontractor performing 100 percent of contractor hours.
Quick answers
Who was awarded contract 75F40125F19018?
75F40125F19018 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on September 26, 2025.
How much is contract 75F40125F19018 worth?
The government has obligated $242,925 on 75F40125F19018.
Is contract 75F40125F19018 an order under another contract?
Yes. 75F40125F19018 is a delivery order under 75F40123D00021, an indefinite delivery contract.
Was contract 75F40125F19018 competed?
The extent of competition for 75F40125F19018 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award